Since Moonshot Composting's inception, its subscribing businesses and residents have diverted more than 209 thousand pounds of food waste from landfills. Photo courtesy of Moonshot

From landfills leaking into the water supply to reports of recycling being dropped in landfills, Houston's sustainable future has been mired by waste management faux-pas. According to a fact sheet from the City of Houston, 81 percent of trash in Houston ends up in landfills. Brothers-in-law Chris Wood and Joe Villa co-founded Moonshot Composting in hopes of improving Houston's environmental future.

After the birth of his second child, Wood stepped away from his career as a corporate attorney to stay home and find new opportunities outside of law.

"Just through conversations and reading, it became clear that Houston had not yet picked up the pace on diverting food waste as a city," says Wood.

Composting, a method of decomposing organic solid wastes that's growing in popularity, diverts trash like food and paper towels into compost that can be used to grow plants. While letting your waste have a second life sounds like a sweet deal, it's also a sustainable one. More compost means less waste in landfills, a major contributor to harmful greenhouse gas emissions.

The scarcity of composting options left Wood with answers to what was holding Houston back. Was it the sheer size of the city alone? He reached out to Villa, who had spent 15 years in transportation logistics, with a laundry list of questions.

"How do we minimize a real waste stream that's going to the landfill and maximize streams of materials that we're not using anymore to be reused in some new form or fashion," poses Wood.

It wasn't long before Villa and Wood entrenched themselves in research. The two traveled to South Carolina for the U.S. Composting Council's annual conference last January and left feeling inspired to bring their idea to fruition. Like the rest of the world, they couldn't have anticipated that COVID-19 would rattle the nation in the weeks to come and cause a string of lockdowns across the U.S.

Brothers-in-law Chris Wood and Joe Villa co-founded Moonshot Composting in hopes of improving Houston's environmental future. Photo courtesy of Moonshot

"Even though the pandemic hit before we launched our business, we were far enough along that we felt like we could do this safely," says Wood. A benefit of Moonshot Composting's structure was its drop-off and pick-up style program for both businesses and consumers.

The two co-founders weren't the only people finding a newfound passion for. According to Google Trends, users were searching for ways to compost at home at increased rates after the first stay-at-home order was announced last March. As people were learning to back sourdough and building their puzzle collections, they were also wondering how to be more sustainable in their households. The keywords "composting at home" surged to its greatest peaks during April, July and September in 2020.

With a growth-focused plan to help Houston be greener, Moonshot Composting recently participated in cohort 3 of The Ion's Smart and Resilient Cities Accelerator, where Villa and Wood gained insights from mentors and business leaders.

The momentum has continued with the company's latest release: a digital Diversion Dashboard for residential customers who track their composting totals, compare their composting to other communities, and share the statistics on social media.

"We knew from the time that we started, that there was an opportunity to introduce technology to improve people's behavior around the trash can," says Wood. "Our plan was to operate for at least a year and understand what it's like to help people compost in their business and at home. From the beginning [of our business], we weighed everything we picked up, because we knew that what you can't measure you can't change."

After putting in place a system to weigh each compost pick-up, the two reached out to their network to bring in outside developers.

The proprietary dashboard also translates the weight of compost to residential impact. Looking at Wood's own dashboard, he can see that his compost weighs the equivalent to 168 pineapples and can notice that his neighborhood is ranked second on Moonshot Composting's list of serviceable areas.

A version of the Diversion Dashboard was first made available to commercial subscribers in the spring on a trial basis. Similar to the consumer platform, the commercial dashboard provides carbon equivalencies to compare your environmental impact like pounds of carbon dioxide removed from the atmosphere and "un-driven" miles.

Moonshot Composting's commercial subscribers include Rice University, Houston Baptist University, The Awty International School, ConocoPhillips, Tacodeli, Snooze Eatery, Ostia, and Amli Residential.

Since Moonshot Composting's inception, its subscribing businesses and residents have diverted more than 209 thousand pounds of food waste from landfills.

While the gamification of composting is new, research on the subject is promising. Gamification has been a powerful tool in the consumer technology apparatus for years. Various studies have analyzed the effectiveness of gamification as a self-motivating tool that has a positive impact on health and wellbeing and increases the meaningfulness of an action.

You can drink from a water bottle that awards you for reaching your daily intake, compete with your friends to see who took the most steps using AppleWatches or FitBits, and run miles to earn money for charity. When not enter some healthy competition with your neighbors using the Diversion Dashboard?

When creating the dashboard, Wood and Villa sought to create a fun way to motivate Houstonians to compost and connect with others over their environmental efforts. While cities like Seattle and San Francisco have established city-wide composting program, the co-founders are enthusiastic about expanding a coalition of eco-savvy Houstonians.

"Whether it's good or bad, we [Houston] don't always lead with government mandates, but we always lead with businesses working together with communities to try to do good," says Wood, "We can do it through innovation and that kind of matches the Houston spirit."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.